11.43

0.08% 0.010

Oric Pharmaceuticals Inc (ORIC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$11.44

Aprire:

$11.55

Volume 24 ore:

229.90K

Relative Volume:

0.21

Capitalizzazione di mercato:

$974.96M

Reddito:

Utile/perdita netta:

$-119.87M

Rapporto P/E:

-6.3149

EPS:

-1.81

Flusso di cassa netto:

$-109.90M

1 W Prestazione:

+3.51%

1M Prestazione:

+11.04%

6M Prestazione:

-1.98%

1 anno Prestazione:

-3.79%

Intervallo 1D:

$11.32

$11.60

Intervallo di 1 settimana:

$11.02

$12.00

Portata 52W:

$3.8951

$14.67

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Nome

Oric Pharmaceuticals Inc

Settore

Healthcare (1167)

Industria

Biotechnology (651)

Telefono

(650) 388-5600

Indirizzo

240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA

Dipendente

122

Cinguettio

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

ORIC's Discussions on Twitter

Confronta ORIC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ORIC Oric Pharmaceuticals Inc	11.44	974.90M	0	-119.87M	-109.90M	-1.81
VRTX Vertex Pharmaceuticals Inc	467.40	120.60B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	565.59	60.80B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	327.76	42.87B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	596.51	36.23B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	297.80	31.54B	3.81B	-644.79M	-669.77M	-6.24

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-08	Iniziato	Ladenburg Thalmann	Buy
2024-10-31	Iniziato	Wells Fargo	Overweight
2024-09-06	Iniziato	Stifel	Buy
2024-02-23	Iniziato	Cantor Fitzgerald	Overweight
2023-09-22	Iniziato	Wedbush	Outperform
2023-03-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-03-21	Aggiornamento	Guggenheim	Neutral → Buy
2023-03-16	Aggiornamento	Oppenheimer	Perform → Outperform
2022-07-18	Ripresa	Oppenheimer	Perform
2022-04-04	Aggiornamento	Citigroup	Neutral → Buy
2022-03-25	Downgrade	H.C. Wainwright	Buy → Neutral
2022-03-22	Downgrade	Citigroup	Buy → Neutral
2022-03-22	Downgrade	Guggenheim	Buy → Neutral
2022-03-22	Downgrade	Oppenheimer	Outperform → Perform
2021-07-06	Aggiornamento	Citigroup	Neutral → Buy
2021-01-25	Downgrade	Citigroup	Buy → Neutral
2020-08-13	Iniziato	Robert W. Baird	Outperform
2020-08-06	Aggiornamento	Citigroup	Neutral → Buy
2020-08-03	Iniziato	H.C. Wainwright	Buy
2020-05-19	Iniziato	Citigroup	Neutral
2020-05-19	Iniziato	Guggenheim	Buy
2020-05-19	Iniziato	JP Morgan	Overweight
2020-05-19	Iniziato	Jefferies	Buy

Mostra tutto

Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie

06:29 AM

Can volume confirm reversal in ORIC Pharmaceuticals Inc.Free Low Risk Equity Screener With Results - Newser

06:29 AM

06:04 AM

Is ORIC Pharmaceuticals Inc. a candidate for recovery playRisk-Managed Strategy Based on Price Analysis - Newser

06:04 AM

05:14 AM

How ORIC Pharmaceuticals Inc. stock performs during market volatility Equity Portfolio Outlook and Performance Summary - Newser

05:14 AM

04:55 AM

ORIC Pharmaceuticals Inc. stock momentum explained Free Community Verified Stock Suggestions - Newser

04:55 AM

02:22 AM

What is the risk reward ratio of investing in ORIC Pharmaceuticals Inc. stockAchieve unparalleled market performance - jammulinksnews.com

02:22 AM

01:18 AM

How ORIC Pharmaceuticals Inc. stock performs during market volatilityFree Stock Market Watch With Alerts - Newser

01:18 AM

Jul 27, 2025

What catalysts could drive ORIC Pharmaceuticals Inc. stock higher in 2025High-yield market plays - jammulinksnews.com

Jul 27, 2025

Competitive Positioning of ORIC Pharmaceuticals Inc.: Is It Leading or LaggingFree Smart Money Stock Analysis - Newser

Jul 27, 2025

New York State Common Retirement Fund Has $215,000 Stock Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Jul 27, 2025

Moving Average Trends for ORIC Pharmaceuticals Inc. Stock: What They IndicateVerified Return Tips - Newser

Jul 27, 2025

Is ORIC Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Free Low-Risk Investment Plans - Newser

Jul 27, 2025

Jul 25, 2025

Can ORIC Pharmaceuticals Inc. stock recover from recent declineBreakthrough profit margins - jammulinksnews.com

Jul 25, 2025

What drives ORIC Pharmaceuticals Inc. stock priceUnprecedented growth rates - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

ORIC Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit wealth increases - Autocar Professional

Jul 24, 2025

What analysts say about ORIC Pharmaceuticals Inc. stockFree Smart Trading Workshop - Autocar Professional

Jul 24, 2025

Arizona State Retirement System Invests $56,000 in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Jul 24, 2025

Jul 23, 2025

Is ORIC Pharmaceuticals Inc. a good long term investmentFree Trading Psychology Coaching - jammulinksnews.com

Jul 23, 2025

Jul 18, 2025

How high can ORIC Pharmaceuticals Inc. stock price go in 2025Massive Gain Ideas - Newser

Jul 18, 2025

Jul 17, 2025

ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 17, 2025

Jul 16, 2025

Why ORIC Pharmaceuticals Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser

Jul 16, 2025

Jul 15, 2025

What makes ORIC Pharmaceuticals Inc. stock price move sharplySmart High Yield Swing Trades - Newser

Jul 15, 2025